Polycystic Ovary Syndrome: all 975 studies

Page 4 of 10. Open to participants first (177), then studies with results posted, then the rest; newest registration first within each.

• PolyCystic Ovary Syndrome as Suggested Risk Group for Non-Alcoholic Fatty Liver DiseaseCompletedNCT07146815Not applicable
• Letrozole Step up Protocol for Ovulation Induction in Infertile Women With Polycystic Ovary SyndromeCompletedNCT07143682Phase 3
• Anxiety and Depression in Adolescent PCOSCompletedNCT07127458Not applicable
• The Effects Of Low Insulinemic Index Diet On Overweight And Obese Patients With Polycystic Ovary SyndromeCompletedNCT07124767Not applicable
• LH/FSH, Testosterone, Prolactin, and Ferritin in PCOS Patients in JordanCompletedNCT07112768
• Liver Stiffness And Steatosis Assessment In Women With Polycystic Ovary Syndrome Using FibroscanCompletedNCT07027332
• Association of Vitamin D Status With Metabolic Markers in Adolescents With Polycystic Ovary SyndromeCompletedNCT06970821
• Endocrine Disruptors, Toxic and Essential Chemical Elements and Polycystic Ovary SyndromeCompletedNCT06968455
• Effect of Theronomic Ova-All Care on Biomarkers of Ovarian Health in Adult Female With Polycystic Ovarian SyndromeActive, not recruitingNCT06963840Phase 2
• Semaglutide in Women With Polycystic Ovary Syndrome and ObesityCompletedNCT06896981Phase 2/3
• Assessment of the Impact of Polycystic Ovary Syndrome on Women's SexualityCompletedNCT06887296
• Intermittent Fasting Diet Versus Resistive Exercise Program on Insulin Resistance in Obese Women With P.C.O.SCompletedNCT06882291Not applicable
• Effect of Ultrasound Acupoints on Patients With Polycystic Ovary SyndromeCompletedNCT06844903Not applicable
• The Combined Effect of N-Acetyl Cysteine and Metformin in Polycystic Ovary Syndrome PatientsCompletedNCT06836128Phase 3
• Oxidative Stress in Polycystic Ovary SyndromeCompletedNCT06826625
• Clinical、metabolomics and the Study of Intestinal Flora of Jinfeng Pills in the Treatment of Polycystic Ovary SyndromeActive, not recruitingNCT06823830Phase 4
• Comparison of Clomid and Lezra With Lezra for Ovulation Induction in Clomid Resistant PCOS CaseCompletedNCT06813118Phase 1
• Progesterone Primed Ovarian Stimulation Versus GnRH Antagonist Protocols in Women with Polycystic Ovarian SyndromeCompletedNCT06812559
• Intermittent Fasting (IF) Has Gained Recognition As a Promising Weight Loss Approach That Improves Body Weight, Insulin Resistance, and Metabolism. While Standard Diets Are Common in PCOS Management, IF May Address the Underlying Causes of Weight Gain and Offer Additional Metabolic BenefitsCompletedNCT06804044Not applicable
• Treatment of Menstrual Cycle Alterations in AdolescentsCompletedNCT06800170Not applicable
• Changes in Hormonal Profile and Body Mass Index in Women With Polycystic Ovary Syndrome After Probiotic IntakeCompletedNCT06761625Not applicable
• Polycystic Ovary Syndrome and Urinary Tract Stones: a BMI-Adjusted Analysis in Iraqi WomenCompletedNCT06729359
• The Role of L-arginine in Polycystic Ovary SyndromeCompletedNCT06728644Not applicable
• Oxytocin Versus Human Chorionic Gonadotropin as Trigger in Ovulation InductionCompletedNCT06725004Phase 3
• Treatment of Women With Hyperandrogenic PCOS With Two Different Ratios of Myo-inositol:D-chiro-inositol: A ComparisonCompletedNCT06715527Not applicable
• Biomechanical Changes in Females with Poly Cystic Ovarian SyndromeCompletedNCT06673901
• Mindfulness-based Stress Reduction in Obese Women With Polycystic Ovary Syndrome (PICOS)CompletedNCT06665789Not applicable
• Treatment of Women With PCOS of Phenotype DCompletedNCT06639698Not applicable
• Resistance Exercise and Peer Support with Bands/balls and Digital Support Among Women with Polycystic Ovary SyndromeCompletedNCT06629883Not applicable
• "KETOGENIC MEDITERRANEAN VERSUS HYPOCALORIC BALANCED DIET ON POLYCYSTIC OVARIAN ADOLESCENTS"CompletedNCT06610812Not applicable
• Can Drospirenone be Used to Prevent LH Surge in Controlled Ovarian Stimulation in PCOS?!CompletedNCT06608186Phase 1/2
• Clusterin Level and Polycystic Ovary SyndromeCompletedNCT06601725
• Evaluation of the Effect of Non-Surgical Periodontal Treatment in Women With Polycystic Ovary SyndromeCompletedNCT06567132Not applicable
• Awareness Of Gynecologists About Role Of Physical Therapy In Management Of Polycystic Ovarian SyndromeCompletedNCT06543225
• Unilateral vs Bilateral Laparoscopic Ovarian Drilling In Clomiphene Citrate Resistant Cases of Polycystic Ovarian SyndromeCompletedNCT06537102Not applicable
• Efficacy of Mazdutide for Treating PCOSCompletedNCT06519656Phase 1/2
• Comparison Between Two Ovulation Induction Therapies and LOD on Clinical Outcomes in CC-Resistant PCOS WomenCompletedNCT06486870Phase 3
• Serum Biomarker Levels Improvement in Poly Cystic Ovarian Syndrome: Impact of Metformin Compared to Healthy ControlsCompletedNCT06479434Not applicable
• Short Term Ketogenic Diet in Polycictic Ovary SyndromeCompletedNCT06469255Not applicable
• History of Polycystic Ovary Syndrome in First-degree RelativesCompletedNCT06442228Not applicable
• The Results of the Mediterranean Diet for PCOSCompletedNCT06442189
• Adolescent Polycystic Ovary Syndrome on a Low-carbohydrate DietCompletedNCT06429618
• The Effect of Polycystic Ovary Syndrome Phenotypes on Quality of Life and Sexual FunctionCompletedNCT06428786
• Effect of Antimullerian Hormone Levels on the Inflammatory Index, Phytochemical Index and NRF Nutrient DensityCompletedNCT06426771
• Effect of ALA Combined With Letrozole on Polycystic Ovary Syndrome Clinical Outcome in Infertile FemalesCompletedNCT06418347Phase 3
• Efficacy of Dihydroartemisinin for Treating PCOSCompletedNCT06417099Phase 2
• Adjuvant Therapy With Letrozole in Induction of Ovulation With Polycystic Ovarian SyndromeCompletedNCT06405178Phase 3
• Letrozole Dose Increments in PCOS Patients Resistant to LetrozoleCompletedNCT06403488Phase 3
• Mediterranean Diet Intervention in Adolescents With Polycystic Ovary SyndromeCompletedNCT06380010Not applicable
• Letrozole Alone Protocol Versus Using Letrozole and HCG ProtocolCompletedNCT06367712Phase 1
• Visceral Adiposity Index Differences Between Subtypes of Polycystic Ovary SyndromeCompletedNCT06358300
• Metabolic Differences Between Subtypes of Polycystic Ovary SyndromeCompletedNCT06342180
• Evaluation of the Venous Thrombotic Biological Profile of Different PCOS Phenotypes: French Cross-sectional StudyActive, not recruitingNCT06339567Not applicable
• A Randomized Controlled Trial of Acupuncture for Insulin Resistance in Patients With Polycystic Ovary SyndromeCompletedNCT06306417Not applicable
• Effects of Traditional Moderate Intensity Training and High Intensity Interval Training in Polycystic Ovarian SyndromeCompletedNCT06303219Not applicable
• Activity of Chronic Inflammation in PCOSCompletedNCT06300593
• Effect of 'Cramp Bites' on Period Cramps in Women Aged 18-25CompletedNCT06227676Phase 2/3
• Semaglutide and Polycystic Ovarian Syndrome: an Emerging Treatment StrategyWithdrawnNCT06222437Phase 1
• The REBALANCE Study - a Prospective, Multicenter, Randomized, Pivotal Study of the May Health SystemTerminatedNCT06206746Not applicable
• Aerobic Training With and Without Resistance Training in Polycystic Ovarian SyndromeCompletedNCT06198348Not applicable
• Effect of Web-Based Module on Nursing Students' Knowledge, Practice and Attitude Regarding Polycystic Ovary SyndromeCompletedNCT06192381Not applicable
• Periodontal Status and Endothelial Dysfunction in Patients With Polycystic Ovary SyndromeCompletedNCT06184412
• Insulin Sensitizers Role in Control of PCOS Vicious Cycle.CompletedNCT06170463Phase 1
• Pivotal Influence of Obesity on Body Composition and Ovarian Doppler in Different Polycystic Ovarian Syndrome PhenotypesCompletedNCT06164132
• A Single Group Study to Evaluate the Effects of a Myo-Inositol and D-Chiro Inositol Supplement on Symptoms Associated With Polycystic Ovary Syndrome and Hormone ImbalanceCompletedNCT06158932Not applicable
• Empagliflozin vs Metformin on Metabolic Dysfunction in Polycystic Ovary Syndrome With or Without Comorbidity or MultimorbidityCompletedNCT06140108Phase 2/3
• Chiglitazar/Metformin in Non-obese Women With PCOSCompletedNCT06125587Phase 2/3
• Effects of a Female Hormone Balance Supplement on Symptoms of Polycystic Ovary Syndrome and Severe Premenstrual SyndromeCompletedNCT06124300Not applicable
• Effect of Vitamin D Supplementation on Testosterone Level in Women With Polycystic Ovary SyndromeCompletedNCT06101147Phase 2
• Low vs. Air Oxygen Concentration CAPA-IVM Culture of Cumulus-oocyte ComplexesCompletedNCT06087354Not applicable
• Interpersonal Psychotherapy in Adolescents With Polycystic Ovary SyndromeCompletedNCT06056453Not applicable
• Glucose Evaluation Through Continuous Glucose Monitors in Polycystic Ovary SyndromeActive, not recruitingNCT06050265Not applicable
• Evaluation of Licorice Root on Metabolic Syndrome in Polycystic Ovary Syndrome FemalesCompletedNCT06043375Not applicable
• Effects of Intermittent Fasting on Polycystic Ovary Syndrome (PCOS) Compared to Standard TreatmentCompletedNCT06031753Not applicable
• Metformin Treatment in Adolescent Patients With PCOS: A Long-term, Winning Metabolic Choice.CompletedNCT06015594Not applicable
• APA on Sleep Quality in Women With PCOSCompletedNCT06009172Not applicable
• The Psychological and Social Impact of PCOSCompletedNCT05982236
• Effects of Combined Metformin and Cabergoline in Comparison With Metformin Only Therapy on Ovarian and Hormonal Activities in Iraqi Patients With PCOSCompletedNCT05981742Phase 2
• Effect of Sitagliptin on Polycystic Ovarian Syndrome PatientsCompletedNCT05972928Phase 2/3
• Dampening the Reproductive Axis With Continuous KisspeptinCompletedNCT05971849Phase 1
• SGLT2 Inhibitors in Treating Patients With PCOSCompletedNCT05966792Not applicable
• Effect of Liraglutide in Obese Women With Polycystic Ovary SyndromeCompletedNCT05965908Phase 3
• Restoring Metabolic and Reproductive Health With Sleep in PCOS Study, CPAP TrialActive, not recruitingNCT05920694Not applicable
• PCOS and US CavitationCompletedNCT05880550Not applicable
• A Study to Evaluate the Effect of Elix Cycle Balance and Daily Harmony on Polycystic Ovary SyndromeStatus unknownNCT05875233Not applicable
• Progesterone Primed Ovarian Stimulation Protocol Versus Antagonist Protocol for PCO PatientStatus unknownNCT05847660Not applicable
• Non-alcoholic Fatty Liver Disease in Women With Polycystic Ovary SyndromeCompletedNCT05843955
• Subclinical Hypothyroidism and Chronic Inflammation in PCOSCompletedNCT05842096Not applicable
• The Effect of Escitalopram in PCOSCompletedNCT05840692Phase 4
• Advanced Glycation End Products and Dietary Intervention in Polycystic Ovary PatientsStatus unknownNCT05830487Not applicable
• Effect of Metformin on Patients With Polycystic Ovary SyndromeCompletedNCT05802212Not applicable
• PriskA Pilot StudyCompletedNCT05785507
• Subclinical Hypothyroidism and Normogonadotropic AnovulationCompletedNCT05782725
• Health Risks and Barriers to Management Across the PCOS LifespanCompletedNCT05769426
• Two Different Dietary Interventions for Girls With Polycystic Ovary SyndromeCompletedNCT05768724Not applicable
• The Effects of Acetyl-L-Carnitine and Myo/Chiro-Inositol in Patients With PCOSCompletedNCT05767515Not applicable
• Combined Chromium With Letrozole Versus Letrozole Only in Induction of Ovulation in Patients With Polycystic Ovary SyndromeCompletedNCT05765305
• Exogenous Ketone Ester in Women with Polycystic Ovary Syndrome.CompletedNCT05762822Not applicable
• Study on the Efficacy and Safety of Chiglitazar Sodium in PCOS With T2DMStatus unknownNCT05760677Phase 1
• Sub-therapeutic GnRH- Antagonist Treatment to Rectify LH Pulsatility in Lean Women With PCOS.CompletedNCT05751252Early Phase 1

← Polycystic Ovary Syndrome overview